Home » Archives » Medical Devices & Diagnostics (Page 13)
By Pallavi Madhiraju on February 20, 2026
Medical Devices & Diagnostics
Project Santa Fe Foundation and Virchow Medical are redefining oncology diagnostics through proactive analytics. Find out what this changes for labs and clinicians.
By Soujanya Ravi on February 19, 2026
Medical Devices & Diagnostics
GE HealthCare secures FDA clearance for next-generation SIGNA MRI. Explore clinical impact, workflow gains, and market implications.
By Soujanya Ravi on February 19, 2026
Medical Devices & Diagnostics
Dror Ortho-Design secures FDA clearance for ZSmile. Explore what pneumatic aligners mean for orthodontic innovation and adoption.
By Soujanya Ravi on February 19, 2026
Medical Devices & Diagnostics
Profusa secures Lumee Oxygen orders ahead of EU MDR clearance. Discover what this means for CLTI monitoring and 2026 commercialization.
By Pallavi Madhiraju on February 19, 2026
Medical Devices & Diagnostics
FDA expands EVO ICL use to ages 21–60. Discover what this means for refractive surgery, safety data, and the shift away from laser vision correction.
By Pallavi Madhiraju on February 19, 2026
Medical Devices & Diagnostics
GE HealthCare expands its BARDA-backed artificial intelligence ultrasound program. Discover what this changes for trauma care and emergency preparedness.
By Pallavi Madhiraju on February 19, 2026
Medical Devices & Diagnostics
UNC Health selects Mevion’s compact proton system. Discover what this means for proton therapy economics, workflows, and academic cancer care.
By Pallavi Madhiraju on February 19, 2026
Medical Devices & Diagnostics
Instanosis wins FDA breakthrough status for its xylazine urine test. Find out why this matters for overdose diagnostics and what challenges remain.
By Pallavi Madhiraju on February 19, 2026
Medical Devices & Diagnostics
Find out how bioAffinity Technologies’ CyPath Lung could reshape decision making for small lung nodules and what risks remain for adoption.
By Pallavi Madhiraju on February 19, 2026
Medical Devices & Diagnostics
BIOEMTECH secures Actinium-225 supply from NorthStar. Find out why isotope access now defines radiopharmaceutical development timelines.